Revelation Biosciences annual current ratio
2019
2020
2021
2022
2023
2024
2025
Revelation Biosciences Current Ratio Growth & History (REVB)
Revelation Biosciences's current ratio was 5.41 for fiscal 2025.
View full Revelation Biosciences company overviewRevelation Biosciences annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 5.41 | 1.98 | +57.71% |
| 2024 | 2024-12-31 | 3.43 | 1.25 | +57.18% |
| 2023 | 2023-12-31 | 2.18 | 0.97 | +79.48% |
| 2022 | 2022-12-31 | 1.22 | 0.32 | +36.23% |
| 2021 | 2021-12-31 | 0.89 | 0.70 | +370.68% |
| 2020 | 2020-12-31 | 0.19 | −0.67 | −77.99% |
| 2019 | 2019-12-31 | 0.86 | — | — |
Revelation Biosciences quarterly current ratio
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 6.21 | 2.80 | +81.93% |
| Q1 2026 | 2026-03-31 | 10.02 | 6.42 | +178.06% |
| Q4 2025 | 2025-12-31 | 5.41 | 1.98 | +57.71% |
| Q3 2025 | 2025-09-30 | 6.92 | 5.28 | +322.57% |
| Q2 2025 | 2025-06-30 | 3.42 | 2.32 | +211.60% |
| Q1 2025 | 2025-03-31 | 3.61 | 0.81 | +28.90% |
| Q4 2024 | 2024-12-31 | 3.43 | 1.25 | +57.18% |
| Q3 2024 | 2024-09-30 | 1.64 | −0.98 | −37.50% |
| Q2 2024 | 2024-06-30 | 1.10 | −2.36 | −68.25% |
| Q1 2024 | 2024-03-31 | 2.80 | 0.57 | +25.64% |
| Q4 2023 | 2023-12-31 | 2.18 | 0.97 | +79.48% |
| Q3 2023 | 2023-09-30 | 2.62 | 1.13 | +76.15% |
| Q2 2023 | 2023-06-30 | 3.45 | 2.78 | +410.95% |
| Q1 2023 | 2023-03-31 | 2.23 | 1.25 | +128.48% |
| Q4 2022 | 2022-12-31 | 1.22 | 0.32 | +36.23% |
| Q3 2022 | 2022-09-30 | 1.49 | 1.48 | +14122.99% |
| Q2 2022 | 2022-06-30 | 0.68 | 0.56 | +498.93% |
| Q1 2022 | 2022-03-31 | 0.97 | 0.73 | +301.17% |
| Q4 2021 · Dec 31 | 2021-12-31 | 0.89 | 0.70 | +370.68% |
| Q3 2021 | 2021-09-30 | 0.01 | −10.40 | −99.90% |
| Q2 2021 | 2021-06-30 | 0.11 | — | — |
| Q1 2021 | 2021-03-31 | 0.24 | — | — |
| Q4 2020 | 2020-12-31 | 0.19 | −0.67 | −77.99% |
| Q3 2020 | 2020-09-30 | 10.41 | — | — |
| Q4 2019 | 2019-12-31 | 0.86 | — | — |
Revelation Biosciences current ratio trends
Over the last five fiscal years, Revelation Biosciences's current ratio increased from 0.19 to 5.41, a change of 5.22. The latest reported quarter, Q2 2026, shows 6.21.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Revelation Biosciences source filings ↗